Rovalpituzumab MMAE Antibody
Rovalpituzumab-MMAE is an anti-DLL3 antibody-drug conjugate (ADC) produced in CHO cells, with a predicted molecular weight of 145.02 kDa. This research-grade ADC is utilized in preclinical studies to investigate targeted therapies for small cell lung cancer (SCLC) in both in vitro and in vivo models.
Product Specifications
Target
Gamma-secretase
Conjugation
Unconjugated
Field of Research
Neuroscience, Protein Biochemistry, Stem Cell & Developmental Biology
Molecular Weight
145 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
25231151 3x 1.0 µg DNA
JAKMIP3 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details 
T839-10L 10 L
Terrestrial (Cypripedium) Orchid Medium Without Ammonium Nitrate
Sign In for Pricing
View Details